ACOR
Acorda Therapeutics, Inc.
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
181 hedge funds and large institutions have $826M invested in Acorda Therapeutics, Inc. in 2018 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 67 increasing their positions, 55 reducing their positions, and 21 closing their positions.
Holders
181
Holders Change
+3
Holders Change %
+1.69%
% of All Funds
4.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
67
Reduced
55
Closed
21
Calls
$38.5M
Puts
$15.2M
Net Calls
+$23.3M
Net Calls Change
-$2.58M
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$34.1M |
2 |
2
BlackRock
New York
|
$104M |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$95.1M |
4 |
![]()
4
Marshall Wace
London,
United Kingdom
|
$6.21M |
5 |
5
Balyasny Asset Management
Chicago,
Illinois
|
$5.13M |